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Introduction {#sec1}
============

A hallmark symptom of active pulmonary tuberculosis and a major mechanism of disease transmission is a persistent, sometimes bloody cough. The vast majority of *de novo Mycobacterium tuberculosis* (Mtb) infections are acquired from contact with actively infected, coughing individuals ([@bib28], [@bib49]). Previous hypotheses regarding the mechanism of cough in pulmonary tuberculosis emphasized the role of infection-induced lung irritation and production of inflammatory mediators ([@bib95], [@bib96]). However, empiric evidence for these hypotheses is lacking. We generated an alternative hypothesis that Mtb produces a cough-triggering molecule, thereby enhancing its own transmission.

The cough reflex, which may have evolved as a defense against aspiration of food and gastric contents or inhalation of irritants and infectious particles, is a complex, highly organized, neuromuscular response conserved across mammalian species ([@bib6], [@bib11], [@bib12]). Chemosensory afferent neurons innervating the upper airway and lungs respond to a variety of chemicals, including exogenous noxious molecules like capsaicin, particulates, and cigarette smoke ([@bib64], [@bib65]). Such neurons have been directly visualized in whole mount biopsies of mouse, rat, guinea pig, and human lungs ([@bib23], [@bib24], [@bib79]), where their peripheral terminals encode both ion channel and G-protein-coupled chemosensory receptors ([@bib64], [@bib65]). While pulmonary defense against and response to respiratory infection is considered a major function of the cough reflex, whether virulence molecules from cough-inducing pathogens directly stimulate airway afferent neurons is unknown ([@bib14], [@bib45], [@bib96]).

Recently, diverse species of bacteria have been shown to directly stimulate peripheral nerves. For example, by producing molecules that act on nerve receptors, *Staphylococcus aureus* causes pain ([@bib16]) while *Mycobacterium ulcerans,* a species related to Mtb, causes peripheral anesthesia through interaction of the polyketide mycolactone with neurons ([@bib62]).

Because Mtb is mainly a respiratory pathogen that is predominantly transmitted via cough, cough is initiated by nociceptive neurons ([@bib10]), and bacteria are capable of altering neuronal activity, we hypothesized that Mtb produces a molecule to stimulate cough through activation of respiratory nociceptive neurons thereby facilitating its spread from infected to uninfected individuals. To test this hypothesis, we first demonstrated that guinea pigs with pulmonary tuberculosis cough, and that an organic-phase extract of Mtb consisting primarily of lipid components of its cell wall and fat-soluble molecules is sufficient to induce cough. Exposing nociceptive neurons *in vitro* to the Mtb extract provokes a rapid increase in intracellular calcium, similar to the nociceptive molecule capsaicin. We determined that the active molecule in the Mtb extract is the mycobacterial lipid sulfolipid-1 (SL-1), an important component of the Mtb cell wall ([@bib38], [@bib39], [@bib40], [@bib85]). Genetic disruption of SL-1 biosynthesis results in an Mtb extract that cannot trigger neurons *in vitro* or induce cough in guinea pigs. Finally, we find that guinea pigs infected with Mtb mutants lacking SL-1 synthesis fail to cough. This work represents the identification of a cough-inducing molecule from a virulent human pathogen, with major implications for the pathogenesis and transmission of tuberculosis.

Results {#sec2}
=======

Mtb Infection Induces Cough in Guinea Pigs {#sec2.1}
------------------------------------------

To determine if Mtb produces molecules that induce cough, we first established animal models of coughing, both during Mtb infection and with isolated organic Mtb extracts. Guinea pigs have long been used as a model for Mtb infection ([@bib51], [@bib61], [@bib76], [@bib77]) and as an established experimental model to test isolated compounds for cough induction ([@bib55], [@bib93], [@bib100]). Although it was demonstrated 100 years ago that guinea pigs can transmit Mtb from infected to naive animals ([@bib51], [@bib58], [@bib59], [@bib60], [@bib77]), to date, no studies have reported whether guinea pigs cough in the context of Mtb infection. Thus, to first assess if guinea pigs with pulmonary tuberculosis cough, we infected outbred Hartley guinea pigs with the Mtb Erdman strain via aerosol and measured cough over 24 h using whole-body plethysmography (WBP) ([@bib69], [@bib100]). We infected guinea pigs with \~200 colony-forming units (CFU) of Mtb, placed individual animals in WBP chambers for 24 h every 2 weeks and monitored cough events by plethysmography ([Figures 1](#fig1){ref-type="fig"}A and 1B). Coughs were quantified using a pressure transducer attached to the WBP chamber ([Figure 1](#fig1){ref-type="fig"}A). Each cough was automatically identified by a predetermined algorithm based on the box flow pattern (sharp increase and decrease of box flow) that measures the sharp inspiration and expiration of air during a cough ([Figure 1](#fig1){ref-type="fig"}B). Uninfected control and Mtb-infected guinea pigs showed no statistically significant difference in coughs at 2- or 4-weeks post infection. However, at 6 weeks post-infection, Mtb-infected guinea pigs had twice as many coughs (mean 12 versus 6) compared to control guinea pigs ([Figure 1](#fig1){ref-type="fig"}C). Thus, Mtb-infected guinea pigs have more coughs than uninfected animals 6 weeks after low-dose infection, at a time of maximal lung CFU ([@bib4], [@bib76], [@bib97]).Figure 1Mtb Infection and Mtb Extract Provoke Guinea Pig Coughs(A) Schematic of WBP chamber.(B) Representation of output reading from WBP including bias flow (blue) and bias flow slope (white). Arrows indicate coughs.(C) Cough quantification over a 24 h period every 2 weeks in uninfected and Mtb-infected guinea pigs. Error bars are SEM. ^∗^p \< 0.05 by Mann-Whitney U test.(D) Triggered coughs over a 20-min period in naive, unrestrained guinea pigs after treatment with vehicle (10% MeOh in PBS), WT Erdman Mtb extract (20 mg/mL), or citric acid (0.4 M). Each point represents an individual animal exposed to vehicle, Mtb extract, and citric acid on alternating days. Error bars are SEM. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001 by Friedman's test.

An Organic Extract of Mtb Is Sufficient to Induce Cough in Guinea Pigs {#sec2.2}
----------------------------------------------------------------------

To determine if Mtb produces a mediator of neuronal activation and cough, we performed a Folch extraction ([@bib29]) from Mtb grown in liquid culture to extract polar and non-polar lipids and tested if the organic phase of the extract (hereafter called "Mtb extract") alone was sufficient to induce cough. We chose the organic fraction because the polyketide mycolactone of *M. ulcerans* is also isolated via chloroform:methanol extraction ([@bib32]) and because Mtb has a lipid and organic metabolite rich cell wall with many active molecules ([@bib47]). We then used an established model of cough induction, namely, transient exposure of unrestrained, naive, healthy guinea pigs to noxious molecules ([@bib55], [@bib93]) via a nebulizer and WBP analysis to test if the Mtb extract could trigger cough. As an independent control, we exposed guinea pigs to 0.4 M citric acid, a known cough agonist ([@bib55], [@bib69]). After compound nebulization, we quantified coughs over 20 min as previously reported ([@bib55], [@bib93], [@bib100]). Each animal was exposed to vehicle control, Mtb extract, or citric acid on alternating days separated by a rest day to avoid tachyphylaxis. Nebulization of the vehicle control for the Mtb extract did not trigger coughing, while exposure to the Mtb extract (20 mg/mL final) produced more coughs (mean 8 versus 0.5 coughs in vehicle controls) ([Figure 1](#fig1){ref-type="fig"}D). As expected, nebulization of 0.4 M citric acid resulted in a mean of 12 coughs in 20 min ([Figure 1](#fig1){ref-type="fig"}D). Thus, an Mtb organic-phase extract induces cough in guinea pigs.

Mtb Organic Extract Activates Nociceptive Neurons *In Vitro* {#sec2.3}
------------------------------------------------------------

Having established that the Mtb extract alone is sufficient to induce cough, we next investigated if the Mtb extract activates nociceptive neurons in cell culture using live cell imaging of intracellular calcium dynamics. When nociceptive neurons are triggered by nociceptive agonists, they demonstrate an increase in intracellular \[Ca^2+^\] ([@bib35]) that can be quantified using Ca^2+^ responsive dyes ([@bib43], [@bib46], [@bib50]). To first determine if the Mtb extract can trigger neurons, we used the immortalized mouse embryonic dorsal root ganglion (DRG) cell line, MED17.11, which demonstrates properties of nociceptive neurons ([@bib26]). We loaded MED17.11 cells with the fluorescent semiquantitative Ca^2+^ dye Fluo-4 and monitored fluorescence using live cell imaging after exposure to either vehicle control, Mtb extract, or capsaicin, a known transient receptor potential cation channel subfamily V member 1 (TRPV1) agonist ([@bib13]). After treatment with either the positive control capsaicin or the Mtb extract, we observed maximum intracellular \[Ca^2+^\] responses at \~45 s, with the fluorescence returning to baseline by 90 s ([Figure 2](#fig2){ref-type="fig"} A; [Video S1](#mmc2){ref-type="supplementary-material"}). We quantified the maximum change in fluorescence for each individual cell in the field of view using ImageJ and then averaged the response ([Figure 2](#fig2){ref-type="fig"}B). Not every cell responded to the Mtb extract or capsaicin, suggesting that the differentiated MED17.11 cells may not be a uniform population. However, in contrast to the vehicle control (DMSO), both Mtb extract and capsaicin triggered a significant increase in intracellular \[Ca^2+^\] ([Figures 2](#fig2){ref-type="fig"}A and 2B).Figure 2Mtb Extract Increases Intracellular \[Ca^2+^\] in Nociceptive Neurons(A) Bright-field images and images of cells at 488 nm taken at 0 and 45 s after treatment of Fluo-4 loaded MED17.11 cells with DMSO (vehicle), Mtb extract (0.4 mg/mL final), or capsaicin (200 nM).(B) Quantification of the average max ΔF/F~0~ of capsaicin-positive nociceptive neurons after the treatment in A. Error bars are SEM. ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001 by Kruskal-Wallace test.(C--N) Fura-2 (mouse) or Fluo-8AM (human) intracellular calcium assays (Ex 340/380, Em 510 nm) using MED17.11 cells (C--E), primary mouse DRG neurons (F--H), primary mouse nodose/jugular ganglia neurons (I--K), and primary human DRG neurons (L--N). Dashed lines indicate the time when the Mtb extract was added. For each cell type, the ΔF/F~0~ trace of representative neurons from a single dish (C, F, I, and L), the average ΔF/F~0~ trace for all neurons in a single dish (D, G, J, and M), and the maximum change in ΔF/F~0~ fluorescence ratio combining the data from individual neurons in 2 or more experiments (minimum 50 cells) (E, H, K, and N) are shown. For experiments with mouse (MED17.11, DRG, and nodose/jugular) neurons, representative experiments of at least 3 are shown. For human DRG neurons, shown is the combined data from two donors. Error bars in (E), (H), (K), and (N) are SEM. ^∗∗∗∗^p \< 0.0001 by paired Student's t test.

Video S1. Increased Intracellular \[Ca^2+^\] of MED17.11 Cells Loaded with Fluo-4 in Response to Mtb Extract, Related to Figure 2

While Fluo-4 allows for a semiquantitative determination of intracellular \[Ca^2+^\], the ratiometric dye Fura-2 allows quantification of intracellular \[Ca^2+^\] by determining the ratio of Fura-2 excitation at 340 nm and 380 nM ([@bib43], [@bib46], [@bib50]). Thus, to confirm our results with Fluo-4, we exposed Fura-2-loaded MED17.11 neurons to DMSO, the Mtb extract, and capsaicin and monitored intracellular \[Ca^2+^\] over time for individual cells. Each compound was perfused onto the neurons and then removed by washing before the following compound was added ([Figure 2](#fig2){ref-type="fig"}C). While DMSO perfusion did not alter intracellular \[Ca^2+^\], Mtb extract triggered a rise in intracellular \[Ca^2+^\] at \~45 s after exposure as can be seen in individual cell traces ([Figure 2](#fig2){ref-type="fig"}C), the average response ([Figure 2](#fig2){ref-type="fig"}D), and the quantified response for all cells ([Figure 2](#fig2){ref-type="fig"}E). The response of MED17.11 cells to Mtb extract was limited to capsaicin-responsive neurons, as capsaicin non-responsive cells did not demonstrate a significant increase in intracellular \[Ca^2+^\] ([Figure S1](#figs1){ref-type="fig"} ). Furthermore, the Ca^2+^ source was predominantly from intracellular Ca^2+^ stores as there was no difference in the change in intracellular \[Ca^2+^\] if MED17.11 neurons were bathed in Ca^2+^-containing or Ca^2+^-free media during activation by Mtb extract ([Figure S2](#figs2){ref-type="fig"} ). To determine whether the specificity of neuronal activation was restricted to the organic compartment, we tested if other Mtb compartments, including cell membrane extracts, cytosol fractions, soluble proteins from the cell wall, Triton X-114 soluble proteins, or secreted proteins can activate MED17.11 neurons. Only the total lipid compartment activated neurons ([Table 1](#tbl1){ref-type="table"} ).Figure S1Mtb Extract and SL-1 Increases Intracellular \[Ca^2+^\] in Nociceptive Neuron, Related to [Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}(A-D). Fura-2 intracellular calcium assays (Ex 340/380, Em 510 nm) using MED17.11 cells (A), primary mouse DRG neurons (B), primary mouse nodose/jugular ganglia neurons (C) and primary human DRG neurons (D) exposed to Mtb extract. The maximum change in Fura-2 fluorescence ratio for capsaicin responsive (TRPV1+) neurons, capsaicin unresponsive (TRPV1-) and all cells in an experiment (minimum 50 cells) (A-C) are shown. (E-H) Fura-2 intracellular calcium assays using MED17.11 cells (E), primary mouse DRG neurons (F), primary mouse nodose/jugular ganglia neurons (G) and primary human DRG neurons (H) exposed to SL-1. For experiments with mouse (MED17.11, DRG and nodose/jugular) neurons, representative experiments of at least 3 are shown. For human DRG neurons, shown is the combined data from two donors. Error bars represent SEM. ^∗^p \< 0.05, ^∗∗∗^ p \< 0.001, ^∗∗∗∗^p \< 0.0001 by paired Student's t test.Figure S2Effect of Extracellular Ca^2+^ on Intracellular \[Ca^2+^\] Responses of MED17.11 Neurons to Mtb Extract, Related to [Figure 2](#fig2){ref-type="fig"}(A) Quantification of the average max ΔF/F~0~ MED17.11 cells loaded with Fura-2 and treated with vehicle (DMSO) or WT Mtb extract (0.4 mg/mL final). Cells were placed in HHBSS with (DMSO and Mtb extract) or without Ca^2+^ (DMSO NO Ca^2+^ and Mtb NO Ca^2+^). ^∗∗∗^p \< 0.0005, ^∗∗∗∗^p \< 0.0001 by Kruskal-Wallace test.Table 1Mycobacterial Compartments or Compounds and Ca^2+^ ResponseCompoundTriggers Increased \[Ca^2+^\]DMSO−Capsaicin+*M. canettii* total lipids+H37Rv total lipids (normoxic)+H37Rv total lipids (hypoxic)+CDC1551 cell membrane extract−HN878 cell membrane extract−H37Rv cell membrane extract−CDC1551 cytosol fraction−H37Rv cytosol fraction−H37Rv soluble cell wall proteins−H37Rv TX-114 soluble proteins−H37Rv purified lipoarabinomannan (LAM)−CDC1551 culture filtrate proteins−HN878 culture filtrate proteins−Sulfolipid-1+Trehalose monomycolate−Trehalose dimycolate−C24:1 mono-sulfo-galactosyl(β) ceramide (d18:1/24:1)−Galactocerebroside−H37Rv phosphatidylinositol mannosides 1 & 2 (PIM~1,2~)−H37Rv phthiocerol dimycocerosate (PDIM)−Trehalose−Trehalose-2-sulfate+[^3]

To determine if the response to the Mtb extract could be observed in primary mouse neurons, we first isolated and cultured murine DRG neurons, loaded them with Fura-2, and exposed them to the Mtb extract. Similar to the MED17.11 cells, primary mouse DRG neurons exposed to the Mtb extract had a large increase in intracellular \[Ca^2+^\] at \~45 s after perfusion, in contrast to the DMSO control ([Figures 2](#fig2){ref-type="fig"}F--2H), and this response was predominantly in capsaicin-responsive (TRPV1^+^) neurons ([Figure S1](#figs1){ref-type="fig"}). Because the cough reflex is mediated by vagal afferent nerves whose cell bodies are found within the nodose and jugular ganglia ([@bib65]), we also tested if primary nociceptive neurons isolated from murine nodose and jugular ganglia and loaded with Fura-2 could respond to Mtb extract. As with the primary mouse DRG neurons, exposure of mouse nodose/jugular ganglia neurons to the Mtb extract demonstrated a significant increase in intracellular \[Ca^2+^\] entirely in capsaicin-responsive (TRPV1^+^) cells, in contrast to the DMSO control ([Figures 2](#fig2){ref-type="fig"}I--2K and [S1](#figs1){ref-type="fig"}). Thus, an organic Mtb extract is sufficient to activate a mouse nociceptive neuronal cell line, primary mouse DRG neurons, and primary mouse nodose/jugular ganglia neurons *in vitro*.

We next assessed if the nociceptive neuron response to the Mtb extract is evolutionarily conserved in humans by measuring the change in intracellular \[Ca^2+^\] of primary human DRG neurons obtained from deceased donors (n = 2, one male, one female) after exposure to DMSO, Mtb extract, and capsaicin. Human nociceptive neurons were loaded with fluorescent Fluo-8AM dye and intracellular \[Ca^2+^\] measured over time using live cell imaging ([Figures 2](#fig2){ref-type="fig"}L--2N). As with the mouse neurons, DMSO-treated human neurons had a minimal response both with respect to intracellular \[Ca^2+^\] and number of cells responding. Exposure to Mtb extract generated a substantial increase in intracellular \[Ca^2+^\] in multiple cells that were both capsaicin-responsive and non-responsive ([Figures 2](#fig2){ref-type="fig"}L--2N and [S1](#figs1){ref-type="fig"}). Of the total cell population cultured from the human DRG, 56% in one donor and 100% in another donor of capsaicin-responsive (TRPV1^+^) neurons were activated by the Mtb extract ([Table S1](#mmc1){ref-type="supplementary-material"}). Thus, an organic Mtb extract activates both mouse and human nociceptive neurons *in vitro*.

Identification of the Nociceptive-Neuron Activating Molecule as Sulfolipid-1 {#sec2.4}
----------------------------------------------------------------------------

Because we performed all of the preliminary experiments with the Mtb Erdman strain, we next determined the mycobacterial species specificity of the neuron-activating activity of mycobacterial organic extracts. We prepared organic extracts from a variety of mycobacterial species including virulent and non-virulent Mtb species, along with non-tuberculous mycobacteria (NTM), and tested their ability to trigger increased intracellular \[Ca^2+^\] in MED17.11 neurons. Of the extracts tested, neuronal activation overlapped with virulent bacteria in the Mtb complex ([Figure S3](#figs3){ref-type="fig"} ; [Table 2](#tbl2){ref-type="table"} ). We noted that while the virulent Mtb H37Rv strain activated neurons, its attenuated derivative H37Ra ([@bib89], [@bib90]) did not ([Table 2](#tbl2){ref-type="table"}). Because H37Ra has a mutation in the PhoP transcription factor that prevents it from producing the cell wall glycolipid SL-1 ([@bib15]), we obtained pure SL-1 and tested if it was sufficient to activate MED17.11 cells. Consistent with the lack of SL-1 in the H37Ra strain compared to H37Rv, pure SL-1-activated MED17.11 cells ([Figure 3](#fig3){ref-type="fig"} A).Figure S3Intracellular Ca^2+^ Changes of MED17.11 Neurons in Response to Various Bacterial Organic Extracts, Related to [Table 2](#tbl2){ref-type="table"}(A) Quantification of the average max ΔF/F~0~ MED17.11 cells loaded with Fluo-4 and treated with vehicle (DMSO) or organic extracts from a variety of bacterial species (0.4 mg/mL final). ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001 by Kruskal-Wallace test.Table 2Bacterial Strain Extract, Production of SL-1, and Ca^2+^ ResponseBacterial StrainProduces SL-1Triggers Increased \[Ca^2+^\]*M. tuberculosis* Erdman++*M. tuberculosis* HN878++*M. tuberculosis* CDC1551++*M. tuberculosis* H37Rv++*M. tuberculosis* H37Ra−−*M. avium*−+*M. marinum*−−*M. smegmatis* (mc^2^155)−−*M. bovis*−−*M. canettii*++*E. coli* (MACH1)−−[^4]Figure 3Identification and Characterization of SL-1 as the Nociceptive-Neuron Activating Molecule(A) Max ΔF of Fluo-4 loaded MED17.11 cells after treatment with DMSO, Mtb Erdman organic extract (Mtb), sulfolipid-1 (SL-1), trehalose (Tre), trehalose monomycolate (TMM), and trehalose dimycolate (TDM).(B) Structures of SL-1, TMM, TDM, sulfatide, and galactocerebroside.(C) Dose response of SL-1 using Fura-2 loaded MED17.11 cells. EC~50~ calculated by nonlinear regression analysis.(D) Max ΔF/F~0~ of Fluo-4 loaded MED17.11 cells after treatment with DMSO, Mtb organic extract, SL-1, sulfatide (Sulf) or galactocerebroside (Gal).(E) Biosynthetic pathway of SL-1. Stf0 (trehalose 2-sulfotransferase; Rv0295c), PapA2 (polyketide synthase-associated protein A2; acyltransferase; Rv3820c), PapA1 (polyketide synthase-associated protein A1; acyltransferase; Rv3824c), Sap (sulfolipid-1-addressing protein; sulfolipid exporter; Rv3821), Chp1 (cutinase-like hydrolase protein; SL1278 acyltransferase; Rv3822), and MmpL8 (sulfolipid-1 exporter, Rv3823c).(F) Max ΔF/F~0~ of Fluo-4 loaded MED17.11 cells after treatment with wild-type Mtb, MtbΔ*stf0* (Δstf0), and MtbΔ*stf0::stf0* complemented (stf0::stf0) extracts.(G) Max ΔF/F~0~ of Fluo-4 loaded MED17.11 cells after treatment with Mtb extract, pure SL-1, MtbΔ*stf0* (Δstf0), or reactivation of MtbΔ*stf0* extract treated cells by the addition of SL-1. ^∗^p \< 0.05 by paired Student's t test for the MtbΔ*stf0* versus restimulation experiment.(H) Max ΔF/F~0~ of Fluo-4 loaded MED17.11 cells after treatment with extracts from Mtb mutants in the SL-1 synthesis pathway.(I) Max ΔF/F~0~ of Fura-2 loaded MED17.11 cells after treatment with trehalose or synthetic T2S. Experiments are representative of at least 3 replicates. Error bars are SEM. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.005, ^∗∗∗∗^p \< 0.0001 by Kruskal-Wallace (A, D, F, G, H) or Friedman's test (I).

SL-1 is the most abundant sulfated glycolipid located in the outer membrane and cell wall of mycobacteria ([@bib66]), and its presence is unique to pathogenic mycobacteria ([@bib41]). The structure of SL-1 includes a disaccharide trehalose-2-sulfate (T2S) core that is modified with four fatty acyl units (typically 2 hydroxypthioceranic acids, 1 pthioceranic acid, and 1 palmitic acid) ([@bib56]) ([Figure 3](#fig3){ref-type="fig"}B, left). In addition to SL-1, Mtb produces several similarly complex cell wall lipids such as trehalose monomycolate (TMM), trehalose dimycolate (TDM; also known as cord factor), phthiocerol dimycocerosate (PDIM), and others ([Figure 3](#fig3){ref-type="fig"}B, center; [Table 1](#tbl1){ref-type="table"}). Thus, to assess the chemical specificity of the neuronal response to SL-1, we first determined if the response to SL-1 was saturable by performing a dose response experiment using MED17.11 neurons, yielding an EC~50~ for SL-1 of 33 nM ([Figure 3](#fig3){ref-type="fig"}C). We next determined the ability of similarly complex molecules to activate nociceptive neurons by exposing MED17.11 cells to purified Mtb lipids. Of the tested lipids, only SL-1 activated neurons ([Figure 3](#fig3){ref-type="fig"}A; [Table 1](#tbl1){ref-type="table"}). In addition, only extracts from mycobacterial species that produce complex sulfated glycolipids were able to activate MED17.11 neurons including species of the Mtb complex (producers of SL-1) and *M. avium* (producer of a sulfated glycopeptidolipid but not SL-1) ([@bib70]) ([Figure S4](#figs4){ref-type="fig"} ; [Table 2](#tbl2){ref-type="table"}). Although *M. smegmatis* has been reported to produce small sulfated compounds ([@bib71], [@bib83]), it does not produce SL-1 ([@bib71], [@bib83]), and an organic extract from *M. smegmatis* did not activate MED17.11 neurons ([Figure S4](#figs4){ref-type="fig"}; [Table 2](#tbl2){ref-type="table"}). Finally, mammalian cells including oligodendrocytes and Schwann cells produce a sulfated sphingolipid called sulfatide (3-O-sulfogalactosylceramide) ([Figure 3](#fig3){ref-type="fig"}B, right) that comprises 4% of myelin lipids ([@bib92]). To determine if mammalian sulfatide could also activate nociceptive neurons and to further test the chemical specificity of neuronal activation, we exposed MED17.11 neurons to sulfatide and observed that neither sulfatide nor its non-sulfated analog galactocerebroside ([Figure 3](#fig3){ref-type="fig"}B) were able to trigger increased intracellular \[Ca^2+^\] ([Figure 3](#fig3){ref-type="fig"}D). Thus, SL-1 alone can activate neurons and the neuronal response to SL-1 does not represent a generic response to non-sulfated mycobacterial cell wall glycolipids or sulfated monosaccharide lipids.Figure S4Mass Spectrometry of Mycobacterial Extracts, Related to [Table 2](#tbl2){ref-type="table"}(A) Mass spectra from 2000 -- 3000 m/z of pure SL-1 and mycobacterial extracts.

SL-1 is synthesized in mycobacteria through an enzymatic pathway initiated by sulfation of the symmetric disaccharide trehalose to trehalose-2-sulfate (T2S) by the enzyme sulfotransferase 0 (Stf0), followed by a series of acylation reactions ([Figure 3](#fig3){ref-type="fig"}E) ([@bib87]). Importantly, genetic deletion of *stf0* in Mtb results in a failure to produce SL-1 ([@bib72]). To determine if SL-1 synthesis was necessary for neuronal activation, we tested organic extracts from Mtb Erdman wild-type, Mtb ErdmanΔ*stf0*, and the complemented strain Mtb ErdmanΔ*stf0::stf0* for their ability to activate MED17.11 neurons. While the organic extract from the Mtb ErdmanΔ*stf0* strain failed to activate neurons, both the Mtb wild-type and Mtb ErdmanΔ*stf0::stf0* extracts triggered neuronal activation ([Figure 3](#fig3){ref-type="fig"}F). We also verified that SL-1 was present in the wild-type and Mtb ErdmanΔ*stf0::stf0* extracts, but not in the Mtb ErdmanΔ*stf0* extract ([Figure S5](#figs5){ref-type="fig"} ). To confirm that the Mtb ErdmanΔ*stf0* extract did not suppress the response of MED17.11 cells to another ligand, we exposed MED17.11 cells first to the Mtb ErdmanΔ*stf0* extract followed by pure SL-1 and observed that MED17.11 retained their ability to respond ([Figure 3](#fig3){ref-type="fig"}G).Figure S5Mass Spectrometry of SL-1 Pathway Mutants, Related to [Figure 3](#fig3){ref-type="fig"}(A) Mass spectra from 2000 -- 3000 m/z of Mtb WT, MtbΔ*stf0* and Mtb Δ*stf0::stf0*. (B) Mass spectra of Mtb mutants in the SL-1 synthesis pathway in the regions of 659-661 m/z (for SL659), 1277-1279 m/z (for SL1278) and 2000-3000 m/z (for SL-1). Stf0 (Trehalose 2-sulfotransferase; Rv0295c), PapA2 (Polyketide synthase-associated protein A2; acyltransferase; Rv3820c), PapA1 (Polyketide synthase-associated protein A1; acyltransferase; Rv3824c), Sap (Sulfolipid-1-addressing protein; sulfolipid exporter; Rv3821), Chp1 (Cutinase-like hydrolase protein; SL1278 acyltransferase; Rv3822), MmpL8 (Sulfolipid-1 exporter, Rv3823c). Arrows identify SL659 and SL1278.

In order to characterize the minimal SL-1 precursor capable of activating nociceptive neurons, we prepared extracts from Mtb mutants at each step of the SL-1 biosynthetic pathway and tested their ability to activate MED17.11 cells. As expected from prior studies ([@bib17], [@bib53], [@bib87]), pathway mutants accumulated precursor molecules through mass action ([Figure S5](#figs5){ref-type="fig"}). Interestingly, while an extract from the Mtb ErdmanΔ*stf0* again failed to activate neurons, extracts from mutants in all subsequent steps retained a modest ability to activate neurons ([Figure 3](#fig3){ref-type="fig"}H). Thus, our genetic analysis demonstrated that while SL-1 precursors such as SL-659 and SL-1278 potentially activate neurons, T2S is the minimal molecule capable of neuronal activation in Mtb extracts. To confirm this result, we chemically synthesized T2S ([Figure S6](#figs6){ref-type="fig"} ) and tested if it could also activate neurons. Consistent with the genetic results ([Figure 3](#fig3){ref-type="fig"}H), while the non-sulfated precursor trehalose did not activate neurons, chemically synthesized T2S activated neurons ([Figure 3](#fig3){ref-type="fig"}I). Thus, synthesis of SL1 is both necessary and sufficient to activate MED17.11 neurons *in vitro*, and the organically synthesized precursor T2S also activates MED17.11 neurons.Figure S6Synthesis of Trehalose-2-Sulfate and Corresponding NMR Spectra, Related to [Figure 3](#fig3){ref-type="fig"}(A) Synthesis of trehalose-2-sulfate from trehalose. (B) ^1^H NMR spectrum. (C) COSY NMR spectrum.

SL-1 Activates Primary Mouse and Human Neurons {#sec2.5}
----------------------------------------------

We next determined if SL-1 was sufficient to activate primary mouse DRG and nodose/jugular ganglia-derived neurons as well as human DRG neurons. MED17.11 neurons ([Figures 4](#fig4){ref-type="fig"} A--4C), primary mouse DRG neurons ([Figures 4](#fig4){ref-type="fig"}D--4F), primary mouse nodose/jugular ganglia neurons ([Figures 4](#fig4){ref-type="fig"}G--4I), or primary human DRG neurons ([Figures 4](#fig4){ref-type="fig"}J--4L; [Table S1](#mmc1){ref-type="supplementary-material"}) were loaded with Fura-2 (MED17.11 or mouse) or Fluo-8AM (human) and exposed to either DMSO or SL-1. Focusing on only capsaicin responsive, TRPV1^+^ neurons, individual mouse ([Figures 4](#fig4){ref-type="fig"}A, 4C, 4D, 4F, 4G, and 4I) and human ([Figures 4](#fig4){ref-type="fig"}J and 4L) neurons displayed a large increase in intracellular \[Ca^2+^\] 45 s after exposure to SL-1, similar to our previous observations with the organic Mtb extracts ([Figure 2](#fig2){ref-type="fig"}). Both the average response of capsaicin responsive cells ([Figures 4](#fig4){ref-type="fig"}B, 4E, 4H, and 4K) and the maximum fluorescence per cell ([Figures 4](#fig4){ref-type="fig"}C, 4F, 4I, and 4L) confirmed that SL-1 is a potent agonist of both primary mouse and human capsaicin-responsive, TRPV1^+^ neurons. The population of capsaicin non-responsive cells did not show a specific response to SL-1 ([Figure S1](#figs1){ref-type="fig"}). Thus, SL-1 alone is sufficient to activate both mouse and human nociceptive neurons.Figure 4SL-1 Activates Both Mouse and Human DRGs *In Vitro*(A--C) Intracellular \[Ca^2+^\] measurement using MED17.11 cells loaded with Fura-2.(D--F) Intracellular \[Ca^2+^\] measurement using primary mouse DRG neurons loaded with Fura-2.(G--I) Intracellular \[Ca^2+^\] measurement using primary mouse nodose/jugular ganglia neurons loaded with Fura-2.(J--L) Intracellular \[Ca^2+^\] measurement using primary human DRG neurons loaded with Fura-8AM. Dashed lines represent the addition of SL-1. For each, the ΔF/F~0~ trace of representative neurons from a single dish (A, D, G, and J), the average ΔF/F~0~ trace for all neurons in a single dish (B, E, H, and K), and the maximum change in ΔF/F~0~ fluorescence ratio combining the data from individual neurons in 2 or more experiments (minimum 50 cells) (C, F, I, and L) are shown. For experiments with mouse neurons (MED17.11, DRG and nodose/jugular) representative experiments of at least 3 are shown. For human DRG neurons, shown is the combined data from two donors. Error bars in (C), (F), (I), and (L) are SEM. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001 by Student's t test.

SL-1 Induces Coughing in Naive Guinea Pigs {#sec2.6}
------------------------------------------

Having identified SL-1 as an activator of nociceptive neurons in cell culture, we next evaluated if SL-1 could induce cough in unrestrained, naive, healthy guinea pigs. We nebulized extracts from Mtb Erdman wild-type, Mtb ErdmanΔ*stf0* and Mtb ErdmanΔ*stf0::stf0* (20 mg/mL final), or citric acid (0.4 M) into the WBP chambers and monitored cough for 20 min. As before ([Figure 1](#fig1){ref-type="fig"}D), individual animals were exposed to each extract or compound on alternating days. Both the Mtb Erdman wild-type and the Mtb ErdmanΔ*stf0::stf0* extracts induced a similar number of coughs as citric acid, while the SL-1-deficient Mtb ErdmanΔ*stf0* extract did not induce coughing ([Figure 5](#fig5){ref-type="fig"} A). Furthermore, the response to the Mtb ErdmanΔ*stf0* extract was comparable to the vehicle control ([Figure 5](#fig5){ref-type="fig"}A). To determine if SL-1 alone was a nociceptive, cough-inducing molecule, we exposed healthy guinea pigs to nebulized, pure SL-1 (250 μg/mL) and observed a significant cough response ([Figure 5](#fig5){ref-type="fig"}B). Thus, the presence of SL-1 synthesis in the Mtb Erdman extract is necessary, and pure SL-1 alone is sufficient to induce cough in healthy guinea pigs.Figure 5Nebulized SL-1 and SL-1-Producing Mtb Strains Induce Cough(A) Cough quantification in naive, unrestrained guinea pigs following nebulization of vehicle control (PBS + 10% methanol), wild-type Mtb extract, MtbΔ*stf0* extract (Δstf0), MtbΔ*stf0::stf0* (Δ*stf0::stf0*) extract, or citric acid (0.4 M). All extract concentrations were 20 mg/mL.(B) Cough quantification in naive, unrestrained guinea pigs following nebulization of vehicle control, citric acid (0.4 M), or purified SL-1 (250 μg/mL; estimated max headspace concentration of 12.5 μM). For experiments with Mtb extracts or pure SL-1, data are combined from 2 independent experiments. Error bars are SEM. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.005, ^∗∗∗∗^p \< 0.0001 by Friedman's test.(C) Inoculum and week 6 CFU from the right lung of guinea pigs infected with WT Mtb (WT), MtbΔ*stf0* (Δstf0), and MtbΔ*stf0::stf0* (Δ*stf0::stf0*).(D) Histology of left lung from a representative guinea pig from each treatment group at 6 weeks plus an uninfected control (UI). Scale bar, 2.5 mm. Box magnification shows granulomas.(E) Quantification of (D) showing the percent inflammation from each treatment group (n = 4--5 animals per group). Error bars are SEM.(F) 24-h guinea pig cough quantification of the number of coughs per guinea pig at 3- and 6-weeks post infection from the wild-type Mtb (WT), MtbΔ*stf0* (Δstf0), and MtbΔ*stf0::stf0* (Δ*stf0::stf0*) infected groups and 1 uninfected control group (UI). Each point represents an individual animal. Error bars are SEM. ^∗^p \< 0.05 by Kruskal-Wallis test. Data point identified by outlier analysis indicated with a.

Genetic Disruption of SL-1 Synthesis Prevents Cough during Mtb Infection of Guinea Pigs {#sec2.7}
---------------------------------------------------------------------------------------

Finally, we tested if the presence of SL-1 during an Mtb infection of guinea pigs would impact the incidence of cough. We infected guinea pigs with Mtb Erdman wild-type, Mtb ErdmanΔ*stf0*, or Mtb ErdmanΔ*stf0::stf0* via low dose aerosol, monitored coughing during the course of infection, and included an uninfected group as a control. At day 0, the lung inocula were similar between the Mtb strains, and at 6 weeks, when the animals were beginning to show signs of disease, there was no difference in lung CFUs ([Figure 5](#fig5){ref-type="fig"}C). Likewise, there was no difference between the strains in lung pathology as assessed by histology ([Figure 5](#fig5){ref-type="fig"}D) and quantification of percent lung inflammation ([Figure 5](#fig5){ref-type="fig"}E). However, at the 6-week time point, we observed an increase in coughing in both the Mtb Erdman wild-type infected and Mtb ErdmanΔ*stf0::stf0* cohorts ([Figure 5](#fig5){ref-type="fig"}F). In contrast, except for one outlier animal in the Mtb ErdmanΔ*stf0* cohort, the cough measurements in the Mtb ErdmanΔ*stf0* cohort were comparable to uninfected controls ([Figure 5](#fig5){ref-type="fig"}F). Thus, we conclude that the coughing observed in Mtb-infected guinea pigs is due to the synthesis of SL-1.

Discussion {#sec3}
==========

In this study, we determined that both pulmonary Mtb infection and an organic extract from Mtb induce cough in guinea pigs, and an Mtb organic extract activates a neuronal cell line and primary neurons from both mice and humans. Through a combination of intracellular Ca^2+^ imaging assays with mycobacterial extracts and isolated Mtb lipids, we identified SL-1 as the mycobacterial product responsible for neuronal activation. Genetic ablation of SL-1 synthesis in Mtb prevented neuronal activation and cough induction by Mtb extracts, and SL-1 alone was sufficient to induce cough in naive guinea pigs. Finally, guinea pigs infected with Mtb lacking SL-1 synthesis had a blunted cough response despite having a high bacterial burden and pulmonary pathology consistent with active tuberculosis. Together, our data demonstrate a previously undescribed role for Mtb SL-1 in nociceptive neuronal activation and cough induction.

SL-1 was identified as a major component of the Mtb cell wall more than 60 years ago ([@bib66]), but its activity has remained elusive despite the fact that SL-1 represents 1% of the dry weight of Mtb ([@bib38]). Because virulence of Mtb strains correlated with the abundance of SL-1 ([@bib41]), it was proposed nearly 5 decades ago that SL-1 is an Mtb virulence factor. However, Mtb mutants that fail to produce SL-1 are not attenuated in mice ([@bib34], [@bib84]) or guinea pigs ([@bib84]) although SL-1 deficiency enhances Mtb survival within human macrophages potentially through increased resistance to cationic peptides ([@bib34]). Our findings are consistent with the *in vivo* evidence that SL-1 is not a classic virulence factor that enhances Mtb survival. Based on our cell culture and *in vivo* data, and the observation that only pathogenic mycobacteria produce SL-1 (this report and reviewed in [@bib18], [@bib67]), we uncover a heretofore unrecognized function of SL-1 in nociceptive neuron activation and cough induction. Because cough is a major mechanism of Mtb transmission, we propose that SL-1 is a major contributor to the spread of Mtb from infected to naive individuals.

In addition to Mtb, other mycobacterial species interact with the nervous system through production of complex molecules. For example, *M. ulcerans*, the etiologic agent of Buruli ulcer, causes peripheral anesthesia through the direct activity of a polyketide known as mycolactone ([@bib33]) on peripheral nerves ([@bib62]). To date, mycolactone has not been isolated from Mtb. Conversely, *M. ulcerans* does not produce SL-1 owing to genomic loss of the pks2 locus ([@bib91]), suggesting that each species has evolved unique neuromodulatory molecules to facilitate its own lifestyle. Indeed, neuromodulatory molecules have also been observed in gram-negative and gram-positive organisms. Both lipopolysaccharide from *E. coli* ([@bib74]) and formyl peptides and alpha-hemolysin from *Staphylococcus aureus* ([@bib16]) activate nociceptive neurons to trigger a pain response and inhibit innate immunity ([@bib3], [@bib78]). Thus, direct neuronal engagement by bacterial molecules to either enhance or suppress cellular responses reflects a common virulence strategy of pathogens.

We tested a variety of Mtb isolates and mycobacterial strains for their ability to produce SL-1 and increase intracellular \[Ca^2+^\] in neurons. We observed a direct relationship between the presence of a complex sulfolipid and neuronal activation. Notably, in the matched pair of virulent (H37Rv) and attenuated (H37Ra) strains, SL-1 synthesis is lacking due to a mutation in PhoP ([@bib15]), a phenotype that is corroborated in Mtb mutants of the PhoPR two-component system ([@bib36], [@bib99]). Likewise, an extract from *M. bovis* did not increase neuronal \[Ca^2+^\] and did not have SL-1, in accordance with the observations that *M. bovis*, like H37Ra, is also mutated in the PhoP/PhoR two component system ([@bib37]). While children typically develop either cervical lymphadenopathy or gastrointestinal disease when infected with *M. bovis* owing to ingestion of contaminated dairy products ([@bib21]), primary pulmonary disease occurs in \~50% of adults, in line with probable airborne acquisition either from infected livestock or humans ([@bib21], [@bib98]). Because cough is a feature of pulmonary tuberculosis disease caused by *M. bovis* in both livestock and humans, it is likely that molecules other than sulfolipids are involved in *M. bovis*-mediated cough and transmission. In contrast to *M. bovis* and Mtb H37Ra, an organic extract from the NTM species *M. avium* also activated neurons, consistent with its known production of a complex sulfated glycopeptidolipid ([@bib70]). Chronic cough is a feature of *M. avium* infection in immunocompromised individuals such as those with human immunodeficiency virus (HIV) ([@bib19]), cystic fibrosis ([@bib63]), and Lady Windermere syndrome ([@bib81]). While the general consensus is that most primary pulmonary NTM infections are due to exposure to environmental reservoirs ([@bib20], [@bib42], [@bib48]), there are conflicting data on the possibility of human-to-human transmission of NTM ([@bib7], [@bib8], [@bib27]). Thus, as with *M. bovis*, *M. avium* induced cough and possible airborne transmission occur in an SL-1 independent manner, although for *M. avium* its sulfated glycopeptidolipid may have an analogous activity.

In addition to Mtb, many viral and bacterial organisms such as measles virus, rhinovirus, coronavirus, influenza virus, *Bordetella pertussis*, and *Mycoplasma pneumonia* have cough as a primary symptom and are transmitted via airborne or droplet particles. In the case of airway viruses, it has been proposed that infections can sensitize cough-evoking sensory nerves through upregulation of receptors involved in cough hypersensitivity ([@bib1], [@bib75]), induction of inflammatory cytokines, leukotrienes, and neuropeptides ([@bib25], [@bib30]), and excess production of airway mucous ([@bib73]). Some infections can also cause cough after pathogen clearance. Such post-infectious cough states are similar to pain responses in other tissues that are mediated by nociceptive sensory neurons such that pain signaling commonly outlasts the presence of the original stimulus ([@bib80], [@bib82]). Thus, post-infectious cough might be similar to a chronic pain state where there is ongoing afferent nociceptive input for weeks or months after the injury has healed. Like viral pathogens, Mtb also induces production of a variety of eicosanoids and leukotrienes such as leukotriene B(4) ([@bib94]) that can function as an agonist of the TRPV1 cough receptor ([@bib52]). In addition, extracellular ATP (eATP), a damage-associated molecular pattern ([@bib86]) that can modulate host immunity to Mtb infection ([@bib54], [@bib68]) is a ligand for the purinergic ion channel family (P2X). As the P2X3 receptor has been identified as a cough receptor and possible drug target for chronic cough ([@bib2], [@bib5], [@bib31]), it is also possible that eATP could activate neuronal P2X3 receptors during Mtb infection. In this study, animals infected with an Mtb strain deficient only in SL-1 synthesis had significantly reduced cough. While we did not measure eicosanoids, leukotrienes or eATP in the lungs of infected animals, overall lung inflammation was equal between wild-type and mutant Mtb infected guinea pigs. Furthermore, our observation that pure SL-1 and wild-type Mtb, but not MtbΔ*stf0*, organic extract rapidly induced cough in naive guinea pigs suggests that the mechanism of cough is through direct activation of a neuronal receptor by SL-1 rather than indirectly through production of a secondary metabolite. Thus, we identify SL-1 as a pathogenic bacterial product with cough-inducing activity.

In this work, we demonstrate that SL-1 is necessary and sufficient for cough induction in guinea pigs. Because guinea pigs and humans demonstrate a similar cough reflex to noxious agonists ([@bib11], [@bib55]), SL-1 may also induce cough in humans. Although a link between Mtb virulence and the production of sulfolipids has previously been suggested ([@bib41]), whether SL-1 is required for Mtb transmission remains unknown ([@bib88]). Among the Mtb strains we tested, the HN878 W-Beijing strain is considered to be the most transmissible based on epidemiologic data ([@bib101], [@bib102]), and in our hands it produces SL-1 like the virulent laboratory strains Mtb Erdman, CDC1551, and H37Rv. Because our mass spectrometry analysis was qualitative, we are unable to correlate epidemiologic transmission data with SL-1 production. We are currently developing methods to quantify SL-1 in mycobacterial extracts using mass spectrometry as well as methods to safely test Mtb transmission between experimental animals in large scale. Future work will test the impact of SL-1 and cough in the transmission of Mtb as well as the role of putative SL-1 receptors in these processes.

Our results reveal a previously undescribed role for a mycobacterial glycolipid, SL-1, in neuronal activation and cough induction. These findings provide new directions not only in the study of Mtb pathogenesis and transmission, but also a framework for studies on other respiratory pathogens spread by the airborne route. Identification of unique, cough-inducing, pathogen-derived molecules and their host receptors could lead to the development of novel therapeutics that mitigates the spread of disease. For Mtb, in the absence of an effective vaccine to prevent disease acquisition by naive humans, a cough-inhibiting adjuvant therapy has the potential to significantly reduce transmission with major global health implications.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains***M. tuberculosis Erdman*Laboratory of J. Cox (UC Berkeley)N/A*M. tuberculosis HN878*BEI ResourcesNR-13647*M. tuberculosis CDC1551*BEI ResourcesNR-13649*M. tuberculosis H37Rv*BEI ResourcesNR-13648*M. tuberculosis H37Ra*BEI ResourcesNR-122*M. tuberculosis ErdmanΔstf0*Laboratory of C. Bertozzi (Stanford)<https://doi.org/10.1038/nsmb802>*M. tuberculosis ErdmanΔstf0::stf0*Laboratory of C. Bertozzi (Stanford)<https://doi.org/10.1038/nsmb802>*M. tuberculosis ErdmanΔpapA1*Laboratory of C. Bertozzi (Stanford)<https://doi.org/10.1073/pnas.0611649104>*M. tuberculosis ErdmanΔpapA2*Laboratory of C. Bertozzi (Stanford)<https://doi.org/10.1073/pnas.0611649104>*M. tuberculosis ErdmanΔmmpl8*Laboratory of C. Bertozzi (Stanford)<https://doi.org/10.1073/pnas.1030024100>*M. tuberculosis ErdmanΔchp1*Laboratory of C. Bertozzi (Stanford)<https://doi.org/10.1074/jbc.M111.315473>*M. tuberculosis ErdmanΔsap*Laboratory of C. Bertozzi (Stanford)<https://doi.org/10.1074/jbc.M111.315473>*M. bovis* Karlson and LesselATCCATCC 19210*M. avium*BEI ResourcesNR-49092*M. marinum*Laboratory of J. Cox (UC Berkeley)N/A*M. smegmatis* mc^2^155Laboratory of J. Cox (UC Berkeley)N/A*E. coli* (MACH1)Thermo FisherCat\#C862003**Biological Samples**Human: Primary Human DRG neuronsAnabios<https://anabios.com>**Chemicals, Peptides, and Recombinant Proteins**DMSOFisherCat\#BP231-100TrehaloseSigmaCat\#T9531GalactocerebrosidesSigmaCat\#C4905C24:1 Mono-Sulfo-Galactosyl(β) Ceramide (d18:1/24:1)Avanti Polar LipidsCat\#860571CapsaicinSigmaCat\#M2028Trehalose-2-SulfateThis paperN/ASulfolipid-1BEI ResourcesNR-14845H37Rv PIMsBEI ResourcesNR-14846H37Rv PDIMBEI ResourcesNR-20328H37Rv Cell Membrane ExtractBEI ResourcesNR-14831CDC1551 Cell Membrane ExtractBEI ResourcesNR-14832HN878 Cell Membrane ExtractBEI ResourcesNR-14833Trehalose MonomycolateBEI ResourcesNR-48784Trehalose DimycolateBEI ResourcesNR-14844*M. canettii* total lipidsBEI ResourcesNR-40334H37Rv Normoxic and Hypoxic Total Lipids KitBEI ResourcesNR-48697CDC1551 Cytosol FractionBEI ResourcesNR-14835H37Rv Cytosol FractionBEI ResourcesNR-14834H37Rv Soluble Cell Wall ProteinsBEI ResourcesNR-14840H37Rv TX-114 Soluble ProteinsBEI ResourcesNR-14841H37Rv Purified Lipoarabinomannan (LAM)BEI ResourcesNR-14848CDC1551 Culture Filtrate ProteinsBEI ResourcesNR-14826HN878 Culture Filtrate ProteinsBEI ResourcesNR-14825**Critical Commercial Assays**Primary Human DRG Calcium AssayAnabios<https://anabios.com>**Experimental Models: Cell Lines**Mouse: MED17.11 neuronal cellsLaboratory of M. Nassar (University of Sheffield)RRID:CVCL_4Y33; <https://doi.org/10.1371/journal.pone.0128670>**Experimental Models: Organisms/Strains**Guinea Pig: Male HartleyCharles RiverCrl:HAMouse: Male, Institute for Cancer Research (ICR)EnvigoHsd:ICR (CD-1)Human: Primary Human DRG neuronsAnabios<https://anabios.com>**Software and Algorithms**Buxco FinePointe SoftwareData Sciences International<https://www.datasci.com/products/software/finepointe-software>MetaMorph SoftwareMolecular Devices<https://www.moleculardevices.com>MetaFluor Fluorescence Ratio imaging softwareMolecular Devices<https://www.moleculardevices.com>ImageJ[@bib103]<https://imagej.nih.gov/ij/>Volocity Imaging SoftwarePerkin Elmer<https://www.perkinelmer.com>Prism 8.0GraphPad<https://www.graphpad.com>

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Please direct requests for resources and reagents to Lead Contact, Michael Shiloh (<Michael.Shiloh@utsouthwestern.edu>). Distribution of T2S will require signing a Material Transfer Agreement (MTA) in accordance with the policies of the University of Texas Southwestern Medical Center.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Guinea Pig Studies {#sec4.3.1}

Male Hartley outbred guinea pigs aged 4-6 weeks (weight 200-250 g) were purchased from Charles River Laboratories. Guinea pig health status was monitored daily. For cough studies with Mtb extracts or compounds, animals were naive at the outset of the study. Each experimental animal was treated with vehicle control and extract or compound separated by a day to avoid tachyphylaxis. Guinea pigs were housed in standard cages with Alpha-dri bedding (Shepherd Specialty Papers, Kalamazoo, MI) and provided food and water *ad libitum*. Autoclaved pressed timothy hay cubes (Bioserv, Flemington, NJ) were also provided. Guinea pig experiments were reviewed and approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern (protocol 2018-102280-USDA) and followed the eighth edition of the Guide for the Care and Use of Laboratory Animals. The University of Texas Southwestern is accredited by the American Association for Accreditation of Laboratory Animal Care (AAALAC).

### Mouse Studies {#sec4.3.2}

Institute for Cancer Research (ICR) outbred mice originally purchased from Envigo were bred at the University of Texas at Dallas and used for DRG or nodose/jugular ganglion neuron preparation at 4 weeks of age (weight 18-20 g). Mice were housed in standard cages with aspen wood bedding (Lab Supply, Fort Worth, TX) placed on ventilated rack systems with food and water *ad libitum*. Cotton squares were also provided for nesting. Mouse experiments were reviewed and approved by the Institutional Animal Care and Use Committee at the University of Texas at Dallas (protocol \#14-04) and followed the eighth edition of the Guide for the Care and Use of Laboratory Animals.

### Human DRG Studies {#sec4.3.3}

Primary human nociceptive neurons were isolated from DRGs obtained from two anonymous donors. Donor 1 was a 33-year-old female and Donor 2 was a 20-year-old male. All human DRGs used for this study were obtained from brain-dead organ donors in the United States after obtaining informed consent in accordance to Federal and State regulations, and United Network for Organ Sharing (UNOS) policies (Anabios, San Diego, CA).

### Bacterial strains and culture conditions {#sec4.3.4}

*M. tuberculosis* Erdman was the predominant lab strain used in the study. Wild-type and mutant strains of *M. tuberculosis* were grown in Middlebrook 7H9 medium or on Middlebrook 7H11 plates supplemented with 10% oleic acid-albumin-dextrose-catalase. Freshly prepared tween 80 (Fisher T164-500) was added to liquid medium to a final concentration of 0.05%. All other mycobacterial species ([Table 2](#tbl2){ref-type="table"}, Bacterial strains and [Key Resources Table](#sec4.1){ref-type="sec"}) were grown under similar conditions.

### Cell lines {#sec4.3.5}

MED17.11 cells ([@bib26]) were provided by M. Nassar and were grown using DMEM F12/Glutamax (Thermo) with pen/strep/glutamine (100 I.U./mL penicillin, 100 μg/mL streptomycin, 292 μg/mL L-glutamine, Corning), 50 units/mL interferon gamma (R&D Systems), 0.5% chick embryonic extract (US Biological). The MED17.11 cell line was not authenticated as mouse short tandem repeat testing was not available at the time the studies were performed. Undifferentiated cells were maintained at 33°C and 5% CO~2~ in a humidified incubator. For differentiation and microscopy, 5 × 10^4^ cells were plated onto 35 mm dishes (MatTek) and supplied with differentiation media consisting of DMEM/F12, pen/strep/glutamine, 10% FBS, 10 ng/mL β-FGF (R&D Systems), 0.5 mM di-butyrl cAMP (Sigma), 25 μM forskolin (R&D Systems), 5 μg/mL rock inhibitor Y-27632 (R&D Systems), 100 ng/mL NGF (R&D Systems) and 20 ng/mL GDNF (Sigma). Cells were then maintained at 37°C and 5% CO~2~ in a humidified incubator for 7 days, changing the media every 2-3 days.

Method Details {#sec4.4}
--------------

### Extraction of mycobacterial lipids {#sec4.4.1}

Mycobacteria were grown to an OD~600~ of 0.8 in Middlebrook 7H9 supplemented with 0.01% Tween 80. Then, 200 mL of bacteria were collected by centrifugation at 3500 RPM (Allegra X-14R) for 10 min, resuspended in 2 ml of PBS, and transferred to a glass tube containing 45 ml chloroform-methanol (2:1, vol/vol), and placed in a 58°C water bath for 16 hr. Samples were centrifuged at 2000 RPM (Allegra X-14R) for 5 min, and the upper-phase and cell debris was removed. The remaining organic phase was washed with 8 mL of water followed by a final wash with 2 mL methanol-water (1:1, vol/vol) to remove any remaining polar components. Extracts were then dried down using a RotoVap (IKA HB10) or under nitrogen.

### Mass spectrometry {#sec4.4.2}

Extracts from mycobacteria were first dried down. Dried extracts were then resuspended in 1:1 MeOH:IPA 16 mM NH~4~F at a 4 mg/mL final concentration. Samples were manually infused with a syringe on a quadrupole TOF TripleTOF 6600+ mass spectrometer (SCIEX, Framingham, MA). Electrospray ionization source parameters were as follows: ion source gas 1 (GS1) and gas 2 (GS2) set to 25 and 55 psi, respectively; curtain (Cur) gas set to 25 psi; source temperature of 300°C; and ion-spray voltage of −4,500 V in the negative ionization mode. GS1 and GS2 were zero-grade air, while Cur gas was nitrogen. TOF scans from 100-3000 m/z were collected over 60 s with a flow rate of 10 μL/min. Data were analyzed in PeakView (SCIEX) to identify SL~659~ at 659-661 m/z, SL~1278~ at 1277-1279 m/z, and SL-1 at 2000-3000 m/z.

### Mouse DRG neuron isolation and culture {#sec4.4.3}

Primary mouse DRGs from male ICR mice were extracted, digested and cultured following an established protocol ([@bib9]). Briefly, once dissected, DRGs were placed on ice in Hank's Balanced Salt Solution (HBSS) (Invitrogen). Ganglia were enzymatically dissociated by serial addition of collagenase A (1 mg/ml, Roche Diagnostics, Basel, Switzerland), collagenase D (1 mg/ml; Roche Diagnostics, Basel, Switzerland) and papain (30 μg/ml; Roche Diagnostics, Basel, Switzerland) at 37°C in HBSS, followed by addition of a trypsin inhibitor (1 mg/ml; Roche) that contained bovine serum albumin (bovine serum albumin, 1 mg/ml; Fisher), and the ganglia were further mixed with a polished Pasteur pipette. Disaggregated tissue was then filtered through a 70-μm nylon cell strainer (Falcon; Corning, NY) and resuspended in Dulbecco's modified Eagle's medium F-12 GlutaMax media (Invitrogen) containing 10% fetal bovine serum (Hyclone Laboratories, Inc., South Logan, UT) and 1 × penicillin streptomycin (Invitrogen). The media also contained nerve growth factor (10 ng/ml; Millipore, Billerica, MA) and 5-fluoro-2′-deoxyuridine + uridine (3.0 μg/ml + 7.0 μg/ml; Sigma) to reduce proliferation of glia and fibroblasts. Neurons were cultured on 35 mm dishes (MatTek) coated with poly-D-lysine at 37°C with 95% air and 5% CO~2~ for 3-5 days. All DRGs from 4-6 mice were combined to generate approximately 4-6 dishes of primary cells per experiment.

### Mouse nodose/jugular ganglia neuron isolation and culture {#sec4.4.4}

Primary mouse nodose/jugular ganglia from male ICR mice were extracted, digested and cultured following an established protocol similar to the DRG neuron isolation with slight modifications ([@bib9]). Both sides of the nodose/jugular ganglia from 8-9 mice were combined to generate 2 dishes of primary cells. Neurons were cultured on 35 mm dishes (MatTek) coated with poly-D-lysine (Sigma) and laminin (Sigma) at 37°C with 95% air and 5% CO~2~ overnight.

### Human DRG neuron isolation and culture {#sec4.4.5}

DRGs from 2 human donors from the first thoracic vertebra (T1) through the first sacral vertebra (S1) were used in the present study. The DRGs were stripped of connective tissue and enzymatically digested at 37°C for 2 hr using the methods described by [@bib22]. Dissociated cells were seeded on 96-well plastic bottom plates (Corning) that had been pre-coated with poly-D-lysine. Cells were maintained in culture at 37°C with 5% CO2 in DMEM/F12 supplemented with 10% horse serum (Thermo Fisher Scientific), 2 mM glutamine, 10 ng/mL hNGF (Cell Signaling Technology), 10 ng/mL GDNF (Peprotech), and penicillin/streptomycin (Thermo Fisher Scientific). Half of the culture media was replaced with fresh media every 3 days.

### Live-cell intracellular calcium imaging of MED17.11 neurons and primary mouse DRG and nodose/jugular ganglion neurons {#sec4.4.6}

Cells on 35 mm dishes (MatTek) were loaded with Fluo-4 (Thermo, F10471) or Fura-2 (Thermo, F1221). The dye was removed and 1 mL of HBSS with 20 mM HEPES, pH 7.4 (Thermo, 14170112) was added to each dish for 10 min prior to microscopy. A brightfield image was taken prior to cell stimulation and imaging. Fluo-4 microscopy was performed using Spinning Disk Confocal microscopy at 40X (PerkinElmer) with Volocity imaging software (Perkin Elmer). Cells were imaged at 488 nm. After a 10 s baseline recording, cells were treated with controls or extracts for 90 s and images were obtained every 1 s. A waiting period of 2-5 min was performed between treatment of cells with another molecule to minimize neurons being desensitized.

For Fura-2 experiments, after dye loading, cells were placed in 1 mL of HBSS with 20 mM HEPES for 10 minutes prior to recording. Using an Olympus IX73 inverted microscope, data was acquired with MetaFluor Flourescence Ratio imaging software (Olympus) at excitation wavelengths of 340/380 nm and emission wavelength of 510 nm with image acquisition every 1 s. A 100 s baseline was first recorded after which DMSO was added and recording was obtained for 300 s. Next, compounds or extracts were added with continuous recording for 300 s. Finally, 200 nM was capsaicin added with continuous recording for 300 s.

### Live cell calcium imaging of human DRG neurons {#sec4.4.7}

Experiments were conducted on isolated human DRG neurons from post-mortem donors by Anabios, Inc., San Diego, CA. Cells were loaded with 3 μM Fluo-8-AM (AAT Bioquest) containing 0.1% Pluronic F-127 (Sigma) for 30 min at room temperature. Extracellular solution contained in (mM): 145 NaCl, 3 KCl, 2 CaCl~2~, 1 MgCl~2~, 10 HEPES, 10 glucose adjusted to pH 7.4 with NaOH. Fluo-8-loaded cells were excited at 480 nm and emission was collected at 520 nm with a pcoEDGE sCMOS camera (PCO) mounted on an inverted microscope (Olympus IX71). Images were acquired at 0.2 Hz for 5 min, adding the compound of interest or the vehicle (1% DMSO) after 30 s for a total of 2 min, then washing with the external solution. At the end of the response profiling, an additional application of 200 nM capsaicin (Sigma) was performed to identify the nociceptor human DRG neurons. Image acquisition and data analysis were performed using MetaMorph software (Molecular Devices).

### Whole-Body Plethysmography {#sec4.4.8}

Guinea pigs were placed inside a specialized chamber (Data Sciences International) fitted with a sensitive pressure transducer and an opening for a nebulization device to aerosolize compounds into the chamber. Using the Buxco FinePointe software, the primary cough data recorded were the Bias Flow of the system, the slope of the Bias flow, and the Delta Half Peak Crossing (DHPC) which is the time it takes to transition from the compression phase to the expulsive phase during respiration ([@bib104]). While not used in the cough analysis, other respiratory data, such as respiration rate, were recorded. When cough paroxysms occurred, each individual cough was counted separately.

Nebulization experiments were performed by placing one Hartley guinea pig into a chamber fitted with the nebulization device. All extracts and compounds were resuspended in 10% Methanol in PBS (Vehicle). The first day of the experiment consisted of nebulizing the vehicle for 10 min and recording coughs for 20 min. After a 2-day rest period, each guinea pig received 1 mL of each extract (1 mL at 4 or 20 mg/mL) or 1 mL of sulfolipid-1 (250 μg/ml final). Once all treatment groups were delivered over the course of the experiment, a 2-day waiting period occurred, followed by a treatment of 0.4 M citric acid (positive control). Coughs recorded by the instrument were simultaneously verified by direct observation.

### Aerosol infection and Guinea Pig Plethysmography {#sec4.4.9}

Mtb cultures in 7H9 broth were centrifuged and the pellet was washed 3 times with PBS. The pellet was then resuspended in PBS and centrifuged (Sorvall Legend X1) at 500 rpm to remove clumps. To generate a single cell suspension, the bacteria-containing supernatant was then sonicated in a water bath using an ultrasonic processor with cup horn attachment (Cole Palmer) at 90% intensity for 15 s. Bacteria were then diluted in PBS to yield an OD~600~ of 0.1 (\~3 × 10^7^ CFU/ml), the bacterial suspension placed into the nebulization chamber of a GlasCol aerosolization unit and guinea pigs were infected with \~100-200 CFU. At day 0, the right lung from 3 guinea pigs of each treatment group were homogenized and plated to determine initial CFU. For whole body plethysmography, guinea pigs were placed individually into the nebulization chamber for 24 hr. Depending on the experiment, this was done at either 2, 4 and 6 weeks, or 3- and 6-weeks post infection. For the comparison of wild-type, MtbΔ*stf0* and Mtb*Δstf0::stf0*, infections were staggered to allow for exact comparison of time points. At the completion of the study, the right lung was homogenized to determine CFU and the left lung was fixed in 10% formalin for 16 hr for histology.

### Histology {#sec4.4.10}

Lungs were first fixed in formalin for 16 hr. The formalin was replaced by PBS, lung tissue was embedded in paraffin and sectioned. Sections (5 μm) were then placed on glass slides and stained with hematoxylin and eosin. The sections in their entirety were scanned at 40x magnification using a NanoZoomer S60 digital slide scanner. For quantification of inflammation, an individual blinded to the samples used ImageJ to identify regions of inflammation and calculate percent inflammation by dividing the inflamed area by the total lung area.

### Synthesis of trehalose-2-sulfate (T2S) {#sec4.4.11}

A 5 mL flame-dried reaction vial was purged under argon. To a solution of 52 mg 4,6,4',6'-dibenzylidene α,α-D-trehalose (0.1 mmol) ([@bib44]) in pyridine (0.06M) was added 3 equivalents 25 mg SO~3~⋅pyridine in dimethylformamide (0.5M) dropwise. The reaction was stirred at room temperature for 24 hr. The solvent was then removed under reduced pressure and left to dry overnight under high vacuum. The desired product was separated from starting material and its regioisomer via high performance liquid chromatography (H~2~O (0.1% trifluoroacetic acid (TFA):acetonitrile). The resulting fractions were combined and neutralized with 5% NaHCO~3~ and solvent was removed under reduced pressure. The dimethoxytrityl (DMT) protecting group was cleaved during concentration of the fractions. The remaining water was removed via lyophilization and the resulting mixture contained the product and TFA salt. The TFA salt was removed via a double resin exchange procedure. The obtained mixture was dissolved in water, and added to the Dowex 50WX8 resin (H^+^ form, 10 equiv) in a scintillation vial. After stirring for 2 hr, the resin was filtered off and dried via lyophilization overnight. The product was again dissolved in water along with the Dowex 50WX8 resin (Na^+^ form, 10 equiv). The mixture was stirred for 2 hr. After filtration off the resin, the desired product trehalose-2-sulfate (T2S) was dried via lyophilization overnight as a white crystalline solid in 8.4 mg, 19% overall yield. ^1^H NMR (500 MHz, CD~3~OD): 5.50 (d, *J* = 3.6 Hz, 1H), 5.10 (d, *J* = 3.7 Hz, 1H), 4.18 (dd, *J* = 9.8, 3.6 Hz, 1H), 4.04 (ddd, *J* = 10.2, 4.9, 2.5 Hz, 1H), 3.94 (t, *J* = 9.3 Hz, 1H), 3.90 -- 3.74 (m, 4H), 3.72 -- 3.65 (m, 2H), 3.48 (dd, *J* = 9.7, 3.8 Hz, 1H), 3.46 -- 3.40 (m, 1H), 3.34 (dd, *J* = 8.6, 1.8 Hz, 1H). HPLC-MSD: cal'd for \[C~12~H~22~O~14~S-H^+^\] 421.07, found: 421.10.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical analysis was performed using GraphPad Prism. For *in vitro* intracellular Ca^2+^ assays, either Student's t test for pairwise comparisons, or analysis of variance with Kruskal-Wallace (Fluo-4) or Friedman's test (Fura-2) with correction for multiple comparisons were used. For the restimulation experiment, the MtbΔ*stf0* and restimulated cells were compared using the paired Student's t test. For the SL-1 dose response, the normalized average maximum fluorescence change at each dose was plotted and the EC~50~ was determined using a nonlinear curve fit. For guinea pig experiments with nebulization of Mtb extracts or pure SL-1, Friedman's test for matched, non-parametric data with correction for multiple comparisons was used. For Mtb infected guinea pig cough experiments, the non-parametric Mann-Whitney U test or the Kruskal-Wallis test with correction for multiple comparisons was performed. To identify outliers in animal studies both Dixon's Q test (Q~99%~) and Grubb's outlier test (alpha 0.01) were used, and an outlier was only removed from the statistical analysis if it was identified by both methods.

Data and Code Availability {#sec4.6}
--------------------------

This study did not generate any unique datasets or code. All other data supporting the findings of this study are available in the manuscript or the supplementary materials and available from the authors upon reasonable request.
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Table S1. Response of Human DRG Neurons to Mtb Extract and SL-1, Related to Figures 2 and 4
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[^1]: Present address: Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 30270-901, Brazil
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[^3]: Various mycobacterial compartments including cell wall, lipid and protein mixtures, or isolated compounds were tested for their ability to induce increased \[Ca^2+^\] in MED17.11 neurons.

[^4]: Extracts from various mycobacterial species were prepared and tested for their ability to induce increased \[Ca^2+^\] in MED17.11 neurons. Production of sulfolipid by each bacterial species is also shown.
